Fig. 3

Correlations between clinical features and the proportion of peripheral naive B cells or class-switched B cells at baseline. Correlations between disease activity at baseline and the proportion of peripheral naive B cells or class-switched B cells at baseline (top). Correlations between the rate of improvement in BVAS and the proportion of peripheral naive B cells or class-switched B cells at baseline (bottom). The correlation between immune cell phenotypes and clinical features was analyzed by the Pearson product-moment correlation coefficient. The level of significance was considered p < 0.05. r, correlation coefficient